Filing Flows › Technology › Omnicell (OMCL)
Omnicell (OMCL) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 4, 2026 · Omnicell (OMCL) Q3 2026 earnings results →
Q3 2026 Revenue down 1% year over year to $308M · 4¢ of every $1 of revenue kept as net profit · operating margin 4.9%
Omnicell made $308M in Q3 2026 (-0.9% Y/Y): Product revenues $173M, Service revenues $135M. Operating margin 4.9%, net earnings $11.0M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 4, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $307.9M in Q3 2026, down 1% year over year and down 1% from the previous quarter. Connected devices, software licenses, and other was the largest line at 47% of revenue. Connected devices, software licenses, and other lost $6.5M year over year (down 4%), 232% of the total change.
Gross margin was 44.8%, up 1.5 points from Q3 2025. Operating profit was $14.9M, a 4.9% margin (up 2.2 points year over year). Operating expenses fell 3% while revenue fell 1%. Net earnings were $11.0M, up 102% year over year. The effective tax rate was 30.1%.
Operating cash flow was $33.1M (up 17% year over year), 299% of net earnings. Non-cash charges added back $18.4M of depreciation and amortization and $11.4M of share-based compensation. Working capital and other items used $7.8M. Capital expenditures of $11.4M left free cash flow of $21.7M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 4, 2026 | $308M | -0.9% | 4.9% | $11.0M | $33.1M |
| Q2 2026 | 10-Q | Aug 5, 2026 | $312M | +7% | 10.4% | $24.3M | $68.3M |
| Q1 2026 | 10-Q | May 6, 2026 | $310M | +15% | 5.4% | $11.4M | $54.5M |
| Q4 2025 | 10-K | Feb 26, 2026 | $314M | +2% | 0.1% | −$2.0M | $30.4M |
| Q3 2025 | 10-Q | Nov 5, 2025 | $311M | +10% | 2.7% | $5.5M | $28.3M |
| Q2 2025 | 10-Q | Aug 6, 2025 | $291M | +5% | 2.8% | $5.6M | $42.8M |
| Q1 2025 | 10-Q | May 7, 2025 | $270M | +10% | -4.3% | −$7.0M | $25.9M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Omnicell
Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery. Omnicell is focused on helping its customers define and deliver a cost-effective medication management strategy designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. We are doing this with an industry-leading medication management infrastructure which includes storage and dispensing automation powered by an intelligence ecosystem.
In its own words, from its 10-K, filed Feb 26, 2026.
Omnicell against its Electronic Computers peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -0.9% against the peers' median +36%. Operating margin: 4.9% against the peers' median 10.4%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| OMCL Omnicell | Q3 2026 | $308M | -0.9% | 4.9% |
| AAPL Apple | Q4 FY26 | $114.5B | +12% | 31.1% |
| DELL Dell Technologies | Q2 FY27 | $47.0B | +58% | 11.5% |
| SMCI Super Micro Computer | Q1 FY27 | $19.9B | +298% | 10.4% |
| OSS One Stop Systems | Q3 2026 | $12.6M | +36% | -6.6% |
| SCKT Socket Mobile | Q3 2026 | $3.4M | +9% | -19.0% |
Source: Omnicell 10-Q on SEC EDGAR · CIK 926326 · Electronic Computers
Guidance and outlook
13F: who owns OMCL and who is buying
More on OMCL
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results
- Omnicell guidance history: guided vs reported
- Omnicell gross margin by quarter
- Omnicell operating margin by quarter
- Omnicell net income by quarter
- Omnicell free cash flow by quarter
- Omnicell R&D spending by quarter
- Omnicell capital expenditures by quarter
- Omnicell Product revenues revenue by quarter
- Omnicell Service revenues revenue by quarter